✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Potassium Iodide is a drug marketed by Mission Pharmacal Co and Roxane and is included in two NDAs.
The generic ingredient in POTASSIUM IODIDE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
A generic version of POTASSIUM IODIDE was approved as potassium iodide by MISSION PHARMACAL CO on March 24th, 2016.
Summary for POTASSIUM IODIDE
Recent Clinical Trials for POTASSIUM IODIDE
Identify potential brand extensions & 505(b)(2) entrants
|Y-mAbs Therapeutics, Inc||Phase 2|
|National Cancer Institute (NCI)||Phase 2|
|Pediatric Brain Tumor Consortium||Phase 2|
Anatomical Therapeutic Chemical (ATC) Classes for POTASSIUM IODIDE
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mission Pharmacal Co||POTASSIUM IODIDE||potassium iodide||SOLUTION;ORAL||206211-001||Mar 24, 2016||OTC||No||Yes||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Roxane||POTASSIUM IODIDE||potassium iodide||SOLUTION;ORAL||018551-001||Feb 19, 1982||DISCN||Yes||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|